Pfizer says omicron shots substantially boosted antibodies against BA.5 subvariant in early human data
Jakub Porzycki | NurPhoto | Getty Images Pfizer and its German partner BioNTech on Thursday said their new omicron boosters substantially increased protective antibodies against the dominant omicron BA.5 subvariant for adults in the first direct human data released to the public on the new shots. The study looked at blood samples taken from 40 … Read more
